Jonathan Clayden - Curriculum Vitae#

EDUCATION

• 1989 - 1993 Ph.D.; University of Cambridge: The Asymmetric Epoxidation of Allylic Phosphine Oxides; advisor Dr Stuart Warren)
  
• 1986 - 1989 B.A. (Hons.) First Class, Natural Sciences; University of Cambridge (M.A. 1993)

PUBLICATIONS

• 306 publications totsl, h factor 61, 16500 all-time citations
  
• 118 papers in the last 10 years: 1 x Nature, 1 x Science, 2 x Nature Chem, 1 x Nature Catalysis, 1 x Chem, 7 x J. Am. Chem. Soc., 16 x Angew. Chemie, 10 x Chem. Sci.

PLENARY LECTURES

60 International Plenary lectures in the last 10 years. In 2018-2019 these were in the Netherlands, Finland, France x 2, Switzerland, Germany, Portugal, Brazil, Japan x 3, USA x 3.

EDITED VOLUMES

Comprehensive Organic Synthesis II, vol. 8 (Reduction) (Elsevier, 2014)
Science of Synthesis, volume 36 (Thieme, 2007)
Tetrahedron Special Issue on Atropisomerism (2004)

MAJOR GRANTS (last 10 years)

1. European Research Council Advanced Grant (2020-2025) £ 2,277,725
2. Leverhulme Trust (2020-2023) £ 195,742
3. EU Marie Sklodowska Curie Incoming Fellowship (2019-2021) £ 140,000
4. EPSRC Impact Acceleration Fund (2018-2019) £ 59,961
5. EPSRC Centre for Doctoral Training (2019-2027) £ 6,610,129
6. EPSRC Programme Grant (2017-2022) [20% sharel]] £ 6,496,447
7. European Research Council Proof of Concept Grant (2017-2018) £104,109
8. EU Marie Sklodowska Curie Intra-European Fellowship (2016-2018) £ 131,038
9. Leverhulme Trust (2016-2019) £ 195,989
10. EU Marie Curie Intra-European Fellowship (2014-2016) £ 176,800
11. EPSRC (2014-2017) £ 293,777

VISITING PROFESSORSHIPS

Université Pierre et Marie Curie (Paris VI); University of Florence; École Européenne de Chimie, Polymères, Matériaux, Strasbourg; University of Bordeaux; Institut National des Sciences Appliquées and University of Rouen.

CONSULTANCY

• Technical Update courses for Novartis (Basel CH, Horsham UK, Cambridge MA USA, Emoryville CA USA) and AstraZeneca.
  
• Consultancy: IGM resins (2015-2016), AstraZeneca (2006-2011), Biofocus Ltd. (2008), Janssen (2008), Celltech (2005), Prosidion (2005).